Ozren Vinter

ORCID: 0000-0002-4236-7594
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Myocardial Infarction Research
  • Cardiac Structural Anomalies and Repair
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Coronary Interventions and Diagnostics
  • Cardiac Imaging and Diagnostics
  • Cardiovascular Function and Risk Factors
  • Cardiac Valve Diseases and Treatments
  • Vascular Procedures and Complications
  • Cardiac pacing and defibrillation studies
  • Cardiac electrophysiology and arrhythmias
  • Peptidase Inhibition and Analysis
  • HER2/EGFR in Cancer Research
  • Parathyroid Disorders and Treatments
  • Cardiac Arrhythmias and Treatments
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Pericarditis and Cardiac Tamponade
  • Infective Endocarditis Diagnosis and Management
  • Myasthenia Gravis and Thymoma
  • Folate and B Vitamins Research
  • Intraperitoneal and Appendiceal Malignancies
  • Gout, Hyperuricemia, Uric Acid
  • Aortic aneurysm repair treatments
  • Eosinophilic Disorders and Syndromes
  • Political Systems and Governance
  • Cancer Treatment and Pharmacology

Catholic University of Croatia
2024

Sisters of Charity Hospital
2013-2023

University Hospital Centre Zagreb
2021-2022

Markus Zabel Rik Willems Andrzej Lubiński Axel Bauer Josép Brugada and 95 more David Conen Panagiota Flevari Gerd Hasenfuß Martin Svetlošák Heikki V. Huikuri Marek Malík Nikola Pavlović Georg Schmidt R. Sritharan Simon Schlögl Janko Szavits-Nossan Vassil Traykov Anton E. Tuinenburg Stefan N. Willich Markus Harden Tim Friede Jesper Hastrup Svendsen Christian Sticherling Béla Merkely Béla Merkely Péter Perge Zoltán Salló Gábor Széplaki Nándor Szegedi Klaudia Vivien Nagy Markus Zabel Lars Lüthje Simon Schlögl R. Sritharan Helge Haarmann Leonard Bergau Joachim Seegers Gerd Hasenfuß Pascal Muñoz-Exposito Tobias Tichelbäcker Aleksandra Kirova Gerd Hasenfuß Tim Friede Markus Zabel Simon Schlögl Tim Friede Markus Harden Marek Malík Katerina Hnatkova Marc A. Vos Stefan N. Willich Thomas Reinhold Rik Willems Bert Vandenberk Magdalena Klinika Janko Szavits-Nossan Luka Rotkvić Panayota Flevari Ανδρέας Κατσιμάρδος Dimitrios Katsaras Róbert Hatala Martin Svetlošák Andrzej Lubiński Tomasz Kuczejko Jim Hansen Christian Sticherling David Conen Nikola Pavlović Šime Manola Ozren Vinter Ivica Benko Anton E. Tuinenburg David J. Sprenkeler Agnieszka Smoczyńska Marc A. Vos Axel Bauer Christine Meyer‐Zürn Christian Eick Jesper Hastrup Svendsen Josép Brugada Elena Arbelo Gabriela Kaliská Jozef Martinek Georg Schmidt Michael Dommasch Alexander Steger Stefan Kääb Axel Bauer Moritz F. Sinner Konstantinos D. Rizas Wolfgang Hamm Vassil Traykov Iwona Cygankiewicz Paweł Ptaszyński Krzysztof Kaczmarek Izabela Poddębska Svetoslav Iovev Tomáš Novotný Milan Kozák Heikki V. Huikuri

The EUropean Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter-Defibrillators (EU-CERT-ICD), a prospective investigator-initiated, controlled cohort study, was conducted in 44 centres and 15 European countries. It aimed assess current clinical effectiveness primary prevention ICD therapy.We recruited 2327 patients with ischaemic cardiomyopathy (ICM) or dilated (DCM) guideline indications for prophylactic implantation. endpoint all-cause...

10.1093/eurheartj/ehaa226 article EN cc-by-nc European Heart Journal 2020-03-17
Axel Bauer Mathias Klemm Konstantinos D. Rizas Wolfgang Hamm Lukas von Stülpnagel and 95 more Michael Dommasch Alexander Steger Andrezej Lubinski Panagiota Flevari Markus Harden Tim Friede Stefan Kääb Béla Merkely Christian Sticherling Rik Willems Heikki V. Huikuri Marek Malík Georg Schmidt Markus Zabel Béla Merkely Péter Perge Zoltán Salló Gábor Széplaki Markus Zabel Lars Lüthje Simon Schlögl Helge Haarmann Leonard Bergau Joachim Seegers Gerd Hasenfuß Pascal Muñoz-Exposito Tobias Tichelbäcker Aleksandra Kirova Tim Friede Markus Harden Marek Malík Katerina Hnatkova Marc A. Vos Stefan N. Willich Thomas Reinhold Rik Willems Bert Vandenberk Magdalena Klinika Krapinske Toplice Panayota Flevari Ανδρέας Κατσιμάρδος Dimitrios Katsaras Róbert Hatala Martin Svetlošák Andrzej Lubiński Tomasz Kuczejko Jim Hansen Christian Sticherling David Conen Sestre Milosrdnice Nikola Pavlović Šime Manola Ozren Vinter Ivica Benko Anton E. Tuinenburg Axel Bauer Christine Meyer‐Zürn Christian Eick J Hastrup Josép Brugada Elena Arbelo Gabriela Kaliská Jozef Martinek Michael Dommasch Alexander Steger Stefan Kääb Moritz F. Sinner Konstantinos D. Rizas Wolfgang Hamm Nikolay Vdovin Mathias Klemm Lukas von Stülpnagel Iwona Cygankiewicz Paweł Ptaszyński Krzysztof Kaczmarek Izabela Poddębska Svetoslav Iovev Tomáš Novotný Milan Kozák Heikki V. Huikuri Tuomas Kenttä Ari Pelli Jarosław D. Kasprzak Dariusz Qavoq Sandro Brusich Ervin Avdović Marina Klasan Jan Gałuszka Miloš Táborský Vasil Velchev Rüdiger Dißmann Przemysław Guzik Dieter Bimmel Christiane Lieberz Stefan Stefanow

10.1016/s0140-6736(19)31996-8 article EN The Lancet 2019-09-02
Juhani Junttila Ari Pelli Tuomas Kenttä Tim Friede Rik Willems and 95 more Leonard Bergau Marek Malík Bert Vandenberk Marc A. Vos Georg Schmidt Béla Merkely Andrzej Lubiński Martin Svetlošák Frieder Braunschweig Markus Harden Markus Zabel Heikki V. Huikuri Christian Sticherling Markus Zabel Joachim Seegers Leonard Bergau Gerd Hasenfuß Pascal Muñoz-Exposito Tobias Tichelbäcker Aleksandra Kirova Simon Schlögl R. Sritharan Katharina Jörß J Macken M. A. Misdaq Kornelia Rudolph Markus Zabel Gerd Hasenfuß Tim Friede Axel Bauer Christine Meyer‐Zürn Christian Eick Klinikum rechts der Isar Goerg Schmidt Alexander Müller Michael Dommasch Daniel Sinnecker Stefan Kääb Moritz F. Sinner Axel Bauer Rüdiger Dißmann Ute Burmester Steffen Behrens Martina Gregor Stefan Stefanow Norman Rüb Christian Wolpert Dieter Bimmel Christiane Lieberz Joachim Seegers Lars S. Maier Robert H. G. Schwinger Florian Blaschke Burkert Pieske Gerian Grönefeld Gunnar Klein Ajmal Gardiwal Béla Merkely Gábor Széplaki Péter Perge Janko Szavits Nossan Luka Rotkvić Nikola Pavlović Šime Manola Ozren Vinter Ivica Benko Sandro Brusic Ervin Avdović Marina Klasan Zoran Bakotić Ante Anić Zrinka Jurišić Andrzej Lubiński Emilia Kowalczyk Tomasz Kucejko Agnieszka Czechowska Katarina Wybor Iwona Cygankiewicz Paweł Ptaszyński Jarosław D. Kasprzak Dariusz Qavoq Przemysław Guzik Tomasz Krauze Maciej Sterliński Róbert Hatala Martin Svetlošák Gabriela Kaliská Jozef Martinek Jesper Hastrup Svendsen Karen Thamsborg Jim Hansen Ida-Maria Schloett-Hyldelund Julie Laage-Petersen Rik Willems Bert Vandenberk

OBJECTIVE Diabetes increases the risk of all-cause mortality and sudden cardiac death (SCD). The exact mechanisms leading to in diabetes are not well known. We compared incidence appropriate shocks patients with versus without a prophylactic implantable cardioverter defibrillator (ICD) included retrospective EU-CERT-ICD registry. RESEARCH DESIGN AND METHODS RESULTS A total 3,535 from 12 European centers mean age 63.7 ± 11.2 years (82% males) at time ICD implantation were analysis. 995 (28%)...

10.2337/dc19-1014 article EN Diabetes Care 2019-10-23

BACKGROUND:Amyloidosis is a multisystem disease caused by deposition of dysfunctional protein-amyloid-in various organs. The heart commonly involved, especially in primary (AL) and transthyretin (ATTR) amyloidosis. Most patients present with restrictive cardiomyopathy along other systemic features amyloid deposition. Diagnosing amyloidosis cumbersome based on the patient’s clinical condition findings from electrocardiography, routine laboratory tests, cardiac biomarkers, imaging, biopsy....

10.12659/ajcr.926290 article EN American Journal of Case Reports 2020-11-11

Coronary artery rupture is a rare complication of percutaneous coronary intervention (PCI) that may lead to pericardial effusion frequently accompanied by tamponade. It one the most serious complications with relatively high mortality rate ranging from 7 17%. 1-3 We report case 63-year-old patient acute inferoposterolateral ST-segment elevation myocardial infarction presented 4 hours beginning chest pain. An urgent coronarography left radial access was done and 3-vessel disease found...

10.15836/ccar2016.125 article EN Cardiologia Croatica 2016-03-03

Heart failure is the leading cause of morbidity and mortality worldwide, with ischemic heart disease being one most important etiologic factors.Heart develops due to ventricular remodeling, which leads increases in left end-systolic end-diastolic volumes.In this prospective observational study, we included 101 patients first episode ST-segment elevation myocardial infarction whom percutaneous coronary intervention was conducted within 12 h Thrombolysis Myocardial Infarction III flow...

10.20471/acc.2021.60.03.07 article EN cc-by-nc-nd Acta Clinica Croatica 2021-01-01

Abstract A case presents a 37 years old patient who presented to emergency department with progression of dyspnea. Patient had history pulmonary hypertension due chronic thromboembolism and known, repetitive thrombosis both legs them postthrombotically altered, especially left leg. During his workup he angiography performed which showed evidence in right main branch circumferential pericardial effusion was dominantly locularized behind ventricular posterior wall. Emergency echocardiography...

10.1093/ehjci/jez319.390 article EN European Heart Journal - Cardiovascular Imaging 2020-01-01

E mail: matias.trbusic@gmail.com Amiodarone-induced thyrotoxicosis (AIT) is a serious medical problem especially in patients with dilatative cardiomyopathy because of substantial rate morbidity and mortality. Patients usually present as worsening arrhythmias congestive heart failure. Two forms AIT have been described. Type I occurs preexisting adenomatous goiter results from the excessive hormone production secondary to iodine excess. II found without thyroid disease chemical-induced...

10.15836/ccar.2014.238 article EN Cardiologia Croatica 2014-05-22

2. Trbusic M, Gabric ID, Planinc D, Krcmar T, Pintaric H. What happens when transradialists use transbrachial approach. J Invasive Cardiol. 2013;25 (Suppl E):30E. UvOD: Od 2011. primarni postav naseg laboratorija za invazivnu kardiologiju promijenjen je s femoralnog u lijevi radijalni i danas se oko 95% svih postupaka ucini lijevim ili desnim „nefemoralnim“ pristupom. Primarna perkutana koronarna intervencija (PCI) bolesnika infarktom miokarda elevacijom ST-segmenta (STEMI) najzahtjevniji...

10.15836/ccar.2014.392 article HR Cardiologia Croatica 2014-10-29

Purpose: Radial arterial approach has become the default option for coronary procedures in our cath lab (>90%).However, there are situations when radial is not possible (e.g.congenital anomalies, tortuous configurations, radioulnar loop, weak or absent pulse secondary to previous puncture catheterization).In such situations, a common second-line used (femoral ulnar).Many clinicians considered transbrachial (TB) angiography as high-risk and an obsolete procedure.In literature, complication...

10.15836/ccar.2014.178 article EN Cardiologia Croatica 2014-05-22

Bolesnice s tumorom lijeve dojke, D/D genotipom za ACE i pozitivnom obiteljskom anamnezom kardiovaskularne bolesti imaju veci rizik razvoja kardiotoksicnosti na terapiju trastuzumabom stoga je kod takvih bolesnica potreban poseban obzir pracenja lijecenja.

10.15836/ccar.2014.433 article HR Cardiologia Croatica 2014-10-29

Abstract Introduction Transthyretin amyloidosis (ATTR) is classified as hereditary (hATTR) or acquired (wtATTR). hATTR rare genetic disease with variable penetrance and phenotype, cardiomyopathy (CM) and/or neuropathy being most relevant clinical presentations. The common investigated mutation in Europe Val30Met, predominant endemic areas of Portugal Sweden. On the contrary, p.Asp38Glu an extremely only several cases mentioned a Swedish register isolated Japan, India Canada. Described were...

10.1093/eurheartj/ehad655.1885 article EN European Heart Journal 2023-11-01

Transthoracic echocardiography (TTE)is the primary diagnostic method for assessment of cardiotoxicity and immunotherapy is canceled or suspended if left ventricular ejection fraction (LVEF) reduced more 15% from baseline by 10-15% normal values. In our study, 130 patients (pts) with breast cancer werw treated trastuzumab adjuvantly one year. According to guidelines, TTE was performed before beginning in 3 months periods during therapy. Pts were divided two groups: 51 pts proven listed group...

10.15836/ccar.2013.169 article EN Cardiologia Croatica 2013-05-14
Coming Soon ...